China Compliance Digest: Rx Edition is a weekly compendium of recent news stories about corruption and enforcement in China’s pharmaceutical and medical industries.
This newsletter was designed to provide an insider’s view of the compliance challenges experienced by foreign companies working within these industries in China. In addition, our coverage will alert you to emerging risks and potentially compromising situations as they evolve.
Our writers scour Chinese-language sources to bring you timely information on issues rarely covered in the Western media.
The inaugural issue of China Compliance Digest: Rx Edition compiles relevant stories that have appeared in the newsletter over the past few months. New information has been added to bring the stories up to date.
Click now for a free trial subscription: